Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)

NCT07472972 · clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University of Zurich

Collaborators